|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/02/20 GB Sciences Inc. 10-Q 6/30/20 52:4.7M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 416K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 16K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 16K
12: R1 Document And Entity Information HTML 44K
13: R2 Condensed Consolidated Balance Sheets (Current HTML 107K
Period Unaudited)
14: R3 Condensed Consolidated Balance Sheets (Current HTML 30K
Period Unaudited) (Parentheticals)
15: R4 Condensed Consolidated Statements of Operations HTML 100K
(Unaudited)
16: R5 Condensed Consolidated Statements of Cash Flows HTML 148K
(Unaudited)
17: R6 Condensed Consolidated Statements of Stockholders' HTML 72K
Equity (Unaudited)
18: R7 Note 1 - Background and Significant Accounting HTML 107K
Policies
19: R8 Note 2 - Going Concern HTML 22K
20: R9 Note 3 - Inventory HTML 29K
21: R10 Note 4 - Leases HTML 41K
22: R11 Note 5 - Notes Payable and Line of Credit HTML 47K
23: R12 Note 6 - Convertible Notes HTML 49K
24: R13 Note 7 - Capital Transactions HTML 21K
25: R14 Note 8 - Commitments and Contingencies HTML 29K
26: R15 Note 9 - Related Party Transactions HTML 21K
27: R16 Note 10 - Sale of 50% Membership Interest in GB HTML 28K
Sciences Louisiana, LLC
28: R17 Note 11 - Sale of Membership Interests in Nevada HTML 28K
Subsidiaries
29: R18 Note 12 - Subsequent Events HTML 29K
30: R19 Significant Accounting Policies (Policies) HTML 126K
31: R20 Note 1 - Background and Significant Accounting HTML 74K
Policies (Tables)
32: R21 Note 3 - Inventory (Tables) HTML 29K
33: R22 Note 4 - Leases (Tables) HTML 36K
34: R23 Note 5 - Notes Payable and Line of Credit (Tables) HTML 34K
35: R24 Note 1 - Background and Significant Accounting HTML 22K
Policies (Details Textual)
36: R25 Note 1 - Background and Significant Accounting HTML 74K
Policies - Discontinued Operations (Details)
37: R26 Note 2 - Going Concern (Details Textual) HTML 25K
38: R27 Note 3 - Inventory - Schedule of Inventory HTML 27K
(Details)
39: R28 Note 4 - Leases (Details Textual) HTML 41K
40: R29 Note 4 - Leases - Future Minimum Lease Payments HTML 62K
(Details)
41: R30 Note 5 - Notes Payable and Line of Credit (Details HTML 103K
Textual)
42: R31 Note 5 - Notes Payable and Line of Credit - HTML 42K
Schedule of Debt Payable (Details)
43: R32 Note 6 - Convertible Notes (Details Textual) HTML 199K
44: R33 Note 7 - Capital Transactions (Details Textual) HTML 36K
45: R34 Note 8 - Commitments and Contingencies (Details HTML 55K
Textual)
46: R35 Note 9 - Related Party Transactions (Details HTML 31K
Textual)
47: R36 Note 10 - Sale of 50% Membership Interest in GB HTML 68K
Sciences Louisiana, LLC (Details Textual)
48: R37 Note 11 - Sale of Membership Interests in Nevada HTML 48K
Subsidiaries (Details Textual)
49: R38 Note 12 - Subsequent Events (Details Textual) HTML 72K
51: XML IDEA XML File -- Filing Summary XML 90K
50: EXCEL IDEA Workbook of Financial Reports XLSX 59K
6: EX-101.INS XBRL Instance -- gblx-20200630 XML 1.21M
8: EX-101.CAL XBRL Calculations -- gblx-20200630_cal XML 131K
9: EX-101.DEF XBRL Definitions -- gblx-20200630_def XML 1.19M
10: EX-101.LAB XBRL Labels -- gblx-20200630_lab XML 856K
11: EX-101.PRE XBRL Presentations -- gblx-20200630_pre XML 1.17M
7: EX-101.SCH XBRL Schema -- gblx-20200630 XSD 142K
52: ZIP XBRL Zipped Folder -- 0001437749-20-019228-xbrl Zip 135K
| ex_168442.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of GB Sciences, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zach Swarts, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
|
Date: September 2, 2020 |
/s/ Zach Swarts |
|
|
Zach Swarts, Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/2/20 | |||
| For Period end: | 6/30/20 | NT 10-Q | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/28/20 GB Sciences Inc. 10-K 3/31/20 96:12M RDG Filings/FA 6/27/14 GB Sciences Inc. 10-K 3/31/14 11:1.2M Henrie Gary R/FA 2/12/02 GB Sciences Inc. SB-2 1:166K Elec Delivery Sy… Inc/FA |